Oh oh!!! Interesting developments - so much to digest
So what was Novartis meeting with EPGL for? Would have loved to be a fly on that wall - beeh he he
Let's say, Novartis claim was granted as filed and it covers all sensors, as some suggest, would COO be ok with using EPGL design, if patent granted, and not run the risk of paying royalty to Novartis/Google?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.